Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 2, 2001, Pages 138-158

  Sihorkar, V ^a   Vyas, S P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; AMYLOPECTIN; ANTIBIOTIC AGENT; ANTIFIBROTIC AGENT; CARBOHYDRATE DERIVATIVE; CD8 ANTIGEN; CISPLATIN; DEXTRAN; DNA VACCINE; DOXORUBICIN; GAMMA INTERFERON; GLYCOLIPID; GLYCOPROTEIN; HYBRID PROTEIN; HYDROXYPROLINE; ISONIAZID; LIPOPOLYSACCHARIDE; LIPOSOME; MALEIC ACID DERIVATIVE; MANNAN; MINOCYCLINE; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; POLYSACCHARIDE; PULLULAN; RIFAMPICIN; SISOMICIN; UNINDEXED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN TUMOR; CANCER CELL CULTURE; CANDIDA ALBICANS; CANDIDIASIS; CELL INTERACTION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; HYDROPHOBICITY; IMMUNIZATION; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; LUNG CANCER; LUNG DISEASE; MACROPHAGE ACTIVATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PHYSICAL CHEMISTRY; RAT; REVIEW; SPLEEN CELL; STOMACH CANCER; TARGET CELL; TISSUE SPECIFICITY; TUBERCULOSIS;

ADMINISTRATION, ORAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG THERAPY; GASTRIC MUCOSA; HUMANS; LIPOSOMES; LUNG DISEASES; MACROPHAGE ACTIVATION; POLYSACCHARIDES; VACCINES;

EID: 0035733810     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Endogenous Ligands and carriers in non-immunogenic site-specific drug delivery
2. Antibody-directed liposomes as drug-delivery vehicles
3. Effects of sialic acid derivative on long circulation time and tumor concentration of liposomes
4. The role of protein-linked oligosaccharides in the bilayer stabilization activity of glycophorin A for dioleoylphosphatidylethanolamine liposomes
5. Fusion of sendai virus with negatively charged liposomes as studied by pyrene-labelled phospholipid liposomes
6. A general review of the recent work in immunity (Collected papers of Paul Eahrlich)
7. Characterization of in vivo immunoliposomes targeting to pulmonary endothelium
8. The integrity of proteoliposomes targeted to a model bio-surface
9. Naturally occuring polysaccharide derivatives, which behave as an artificial cell wall on an artificial cell liposome
10. The role of target membranes in fusion with Sendai virus
11. Liposome-bearing glycosphingolipids: Model membrane system for studying molecular mechanism of cell surface carbohydrate-mediated processes
12. Tissue distribution of sialo-glycopeptide bearing liposomes in rats
13. Carbohydrate mediated liposomal targeting and drug delivery
14. A newly developed immunoliposomes-an egg phosphatidylcholine liposome anchored with pullulan bearing both a cholesterol moiety and an IgM fragment
15. Recent aspects in the use of liposomes in biotechnology and medicine
16. Coating of POPC giant liposomes with hydrophobized polysaccharide
17. Structure of pullulan
18. Dextran prodrugs-structure and stability in relation to therapeutic activity
19. Soluble macromolecular carriers for the delivery of anti-tumor drugs
20. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver
21. Molecular weight dependent tissue accumulation of dextrans in rats
22. Comparative study of physicochemical properties of mannan from nine yeasts
23. Liver targeting through pullulan conjugation
24. Enhanced accumulation of sialyl lewis X-carboxymethyl pullulan conjugate in acute inflammatory lesion
25. Macromolecular recognition: Effect of multivalency in the inhibition of binding of yeast mannan to concanavalin A and pea lectins by mannosylated dendrimers
26. Synthesis and biological properties of mannosylated starbust poly(amidoamine) dendrimers
27. Polysaccharide-anchored oil droplets in oil-in-water emulsions as targetable carriers for lipophilic drugs
28. O/w-emulsion of alpha-linolenic acid stabilized with hydrophobized polysaccharide. Its effect on the growth of human colon cancer cells
29. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin
30. Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: Thermal stabilization with refolding of carbonic anhydrase B
31. Self-assembling nanospheres of hydrophobized pullulans in water
32. Diffusion of mixed micelles of bile salt-lecithin in amylopectin gels: A Fourier transform infrared microspectroscopy approach
33. The effects of ageing of amylopectin gels on the diffusion of BSA
34. Growth factor release from amylopectin hydrogel based on copper coordination
35. A novel hydrophobized polysaccharide/ oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas
36. Enhanced IgE response to Candida albicans in postoperative invasive candidiasis
37. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis
38. Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes
39. Bone marrow-derived dendritic cells incorporate and process hydrophobized polysaccharide/oncoprotein complex as antigen presenting cells
40. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan
41. Chitosan: A unique polysaccharide for drug delivery
42. Application of polysaccharide-anchored liposomes in chemotherapy and immuno-therapy
43. Polymer anchored liposomes for drug delivery to target specific organs
44. Improved drug delivery to target specific organs using liposomes anchored with polysaccharides
45. Liposome Membranes. VIII. Fusion and aggregation of egg lecithin liposomes as promoted by polysaccharides
46. Liposome Membranes. VI. Polysaccharide induced aggregation of multilamellar liposomes of egg lecithin
47. Kinetic aspects of polyelectrolyte adsorption: Adsorption of chitin derivatives onto liposomes as a model system
48. Liposomal membranes. XII. Adsorption of polysaccharides on liposome membrane as monitored by fluorescence depolarization
49. Protein anchored and polysaccharide-anchored liposomes as drug carriers
50. Cell specificity of polysaccharide derivatives on liposomal surface
51. Molecular recognition of polysaccharide-anchored liposomes. Importance of sialic acid moiety on liposomal surface
52. Improved stability of black lipid membranes by coating them with polysaccharide derivatives bearing hydrophobic anchor groups
53. The stability and functional properties of proteoliposomes mixed with dextran derivatives bearing hydrophobic anchor groups
54. Polymer-anchored liposomes: Improved liposome stability and release of cytosine arabinoside (Ara-C)
55. Evaluation of in vitro stability of large unilamellar lipsomes anchored with a modified polysaccharide (O-palmitoyl Pullulan)
56. Carboplatin liposomes anchored with O-Palmitoyl Pullulan: In vitro Characterization
57. The potential of liposomes in oral drug delivery
58. Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration
59. Assembly of protein structures on liposomes by non-specific and specific interactions
60. The stabilization and release of hirudin from liposomes or lipid-assemblies coated with hydrophobically modified dextran
61. Polysaccharide coated liposomes for oral drug delivery: Development and characterization
62. Increased lung uptake of liposomes anchored with polysaccharides
63. Improved drug delivery to target specific organs using liposomes anchored with polysaccharides
64. Improved drug delivery directed to specific tissue using polysaccharide-anchored liposomes
65. Unexpected tissue distribution of liposomes anchored with amylopectin derivative and successful use in the treatment of experimental Legionnaires' disease
66. Polysaccharide-anchored liposomes with antimicrobial agents against inracytoplasmic pathogens and fungus
67. Polysaccharide-anchored liposomal amphotericin B for the treatment of murine pulmonary candidiasis
68. Polymeric carrier of proline analogue with antifibrotic effect in pulmonary vascular remodelling
69. Liposomes anchored with chemically modified dextran interact with human endothelial cells
70. Interactions of functionalized dextran-anchored liposomes with vascular smooth muscle cells
71. Lung specific stealth liposomes: Stability, biodistribution and toxicity of liposomal antitubercular drugs in mice
72. Ligand directed macrophage targeting of amphotericin B loaded liposomes: Development and characterization
73. Receptor mediated drug delivery to macrophages in chemotherapy of leishmaniasis
74. The class B scavenger receptor SR-B1 and CD36 are receptors for anionic phospholipids
75. Targetting therapy of human tumor cell line xenografts in nude mice using pullulan-anchored liposome encapsulated with adriamycin
76. Incorporation of enzyme into the brain by means of liposomes of novel composition
77. Glycolipid insertion into liposomes for their targeting to specific organs
78. Targeting chemotherapy of brain tumor using liposome encapsulated cisplatin. Part 2. Pullulan anchored liposomes to target brain tumor
79. Polysaccharide-anchored immunoliposomes bearing anti-CEA Fab' fragment and their internalization by CEA-producing tumor cells
80. Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia
81. Antitumor effect of polysaccharide-anchored liposomal adriamycin on AH 66 hepatoma in nude mice
82. Utility of liposomes anchored with polysaccharide bearing 1-amino-lactose as targeting chemotherapy for AH66 hepatoma cells
83. Increased circulatory half-life of liposomes after conjugation with dextran
84. Serum and salivary antibody responses in rats orally immunized with Streptococcus mutans carbohydrate protein conjugate associated with liposomes
85. Rat T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens
86. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome
87. Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response
88. Oligomannose anchored liposomes as an adjuvant for the induction of cell-mediated immunity
89. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by manna-anchored liposomes and inhibited by anti-interferon-gamma antibody
90. Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome
91. Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-anchored diC14-amidine
92. Liposome oligomannose-anchored with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes
93. Polysaccharide coated liposomes for oral immunization: Development and characterization
94. Synthetic immunostimulants derived from the bacterial cell wall
95. Functionality and applicability of synthetic nucleic acid anlogues
96. Macrophage activation by poly (maleic acid-alt-2-cyclohexyl-1,3-doxap-5-ene) encapsulated in polysaccharide-anchored liposomes
97. Enhancement of antitumor avtivity in mouse alveolar macrophages by immuno-activators encapsulated within polysaccharide-anchored liposomes
98. Development of cell-specific liposomes and its application in biotechnology
99. Improvement of immuno-potentiator activity of polyanionic polymers by encapsulation into polysaccharide-anchored liposomes
100. Potent immunomodulating activity of (polyvinyladenine and vinyladenine-alt-maleic acid) copolymer
101. Mucoadhesion of polymer-anchored liposomes to rat intestine in vitro
102. Enteral absorption of insulin in rats from mucoadhesive chitosan-anchored liposomes
103. Mannan-anchored liposome delivery of Gadolinium-Diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging